Search

You searched for "stent"

570 results found

Paediatric urology: what you need to know for FRCS (Urol)

4 March 2025 | | URO - Paediatric Urology
Lianne Pickett, Urology ST5 at Great Ormond Street Hospital (GOSH), and Ms Neetu Kumar, Consultant Paediatric Urological Surgeon at GOSH, provide expert insights into the key aspects of paediatric urology. Curriculum Paediatric urology contributes one of the eight stations of...

David Newman

1 May 2017 | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would write on a Scottish theme...

Urinary tract stones

9 March 2020 | URO - Endourology & Stones
Case 1 What does this plain X-ray of kidneys, ureters and bladder (KUB) show? What, according to the 2009 The National Institute for Health and Care Excellence (NICE) guidelines, is the most appropriate first-line treatment? What factors do the NICE...

Clinical visit for PCNL experience: Agra, India

1 July 2016 | | URO - Endourology & Stones
In September 2015, I travelled to India for a two-week clinical visit with Professor Madhu Sudan Agrawal at the Global Rainbow Hospital, Agra. Having completed my training I wanted to further develop my skills with PCNL, particularly with regards to...

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology, URO - Technology
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...

In conversation with Roger Kirby

3 September 2020 | URO - Core Urology
We were delighted to catch up with Roger Kirby, new President of the RSM, about his illustrious career in urology. Can you tell us a little bit about what led you into the field of urology and what have been...

The role of specialist therapeutic radiographers in the treatment and care of men with prostate cancer

1 March 2016 | | URO - Urologic Oncology
The Statement of Intent: Cancer Strategy for England: 2015-2020 indicates that the number of people diagnosed with cancer each year will continue to grow rapidly due to the ageing population. There is also a requirement to diagnose and offer patients...

RSM (Royal Society of Medicine) Support and survivorship in urological cancer management: A multidisciplinary update

6 December 2024
Building on last year's Urology Section Cancer Day, this event will feature internationally renowned speakers from across the urology MDT including urologists, radiologists, oncologists, pathologists and specialist nurses. In doing so, we will provide a unique holistic insight into the management of patients with urological cancers relevant to those involved in caring for these patients and those studying for the FRCS(Urol) exam.

BJUI Knowledge

1 July 2021 | | URO - Core Urology
BJUI Knowledge is an online educational platform for urologists. It enables e-learning and provides a record of continuing professional development (CPD). Access to the portal for e-learning and CPD is available online through the website (link below) or an accompanying...

Diving into unfamiliar water – volunteering in critical care

28 January 2021 | | URO - Core Urology, URO - Trauma & Emergency
On the 14th and 15th floor of The Royal London Hospital lay rows of patients infected with COVID-19 battling for their lives at The Queen Elizabeth unit. In response to the pandemic, the hospital rapidly expanded their critical care facility...

Adrenal incidentalomas: what next?

8 January 2024 | | URO - Urologic Oncology, URO - Functional / Reconstructive Urology
An incidentaloma refers to an adrenal lesion >1cm discovered incidentally during radiologic examination. Identifying a malignant and / or functioning lesion is critical for management. However, as the majority of lesions are benign, the challenge is the identification of malignant...

Imaging and surveillance in sporadic renal angiomyolipoma: how and when to monitor effectively

4 March 2025 | | URO - Urologic Oncology
Renal angiomyolipoma (AML) are benign tumours, accounting for approximately 2–3% of all renal neoplasms [1]. Seventy percent of renal AMLs are sporadic, and 20–30% are associated with genetic aetiology. They are composed of smooth muscle, blood vessels, and adipose tissue....